Fort Sheridan Advisors LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1606666
HIGHLAND PARK, IL
Position in ALNY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$512,052
-$50,757 QoQ
Shares Held
1,701
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#479
of 784 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fort Sheridan Advisors LLC holds $2,282,308 across 4 Biotechnology names. ALNY ranks #3 (22.4% of the industry book) .
All Filings in ALNY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $512,052 | 1,701 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $562,809 | 1,701 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $676,402 | 1,701 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $775,656 | 1,701 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $554,679 | 1,701 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $459,304 | 1,701 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $400,262 | 1,701 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $476,626 | 1,733 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $421,119 | 1,733 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $206,339 | 1,078 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $204,755 | 1,078 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $215,944 | 1,078 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||